Likuan Hu
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Oncology
- Cancer Research
- Biomedical Engineering
- Co-authors
- Cuihong WangYuhua JiangShikun WangXiaohong LiChengxin LiuYan WangHaijian WuDedong Ma
- Topics
- Esophageal Cancer Research and Treatment (5 papers)Lung Cancer Research Studies (3 papers)Head and Neck Cancer Studies (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Likuan Hu
24 papers receiving 595 citations
Peers
Comparison fields: 5 of 74
- Pulmonary and Respiratory Medicine 215
- Molecular Biology 207
- Oncology 163
- Cancer Research 113
- Biomedical Engineering 96
Countries citing papers authored by Likuan Hu
This map shows the geographic impact of Likuan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Likuan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Likuan Hu more than expected).
Fields of papers citing papers by Likuan Hu
This network shows the impact of papers produced by Likuan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Likuan Hu. The network helps show where Likuan Hu may publish in the future.
Co-authorship network of co-authors of Likuan Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Likuan Hu. A scholar is included among the top collaborators of Likuan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Likuan Hu. Likuan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 5 | |
| 3 | 44 | |
| 4 | 19 | |
| 5 | 52 | |
| 6 | Lobaplatin combined with docetaxel neoadjuvant chemotherapy followed by concurrent lobaplatin with intensity-modulated radiotherapy increases the survival of patients with high-risk lymph node positive nasopharyngeal carcinoma. | 11 |
| 7 | 20 | |
| 8 | 46 | |
| 9 | 32 | |
| 10 | 4 | |
| 11 | 32 | |
| 12 | 14 | |
| 13 | 70 | |
| 14 | 5 | |
| 15 | 26 | |
| 16 | 4 | |
| 17 | 14 | |
| 18 | 78 | |
| 19 | [Photodynamic therapy of pigmented choroidal melanomas in rabbits]. | 9 |
| 20 | 28 |
About Likuan Hu
Likuan Hu is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology, having authored 24 papers that have together received 603 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (5 papers), Lung Cancer Research Studies (3 papers) and Head and Neck Cancer Studies (3 papers). The work is most often cited by research in Cancer Research (113 citations), Pulmonary and Respiratory Medicine (215 citations) and Oncology (163 citations). Likuan Hu has collaborated with scholars based in China and United States. Frequent co-authors include Cuihong Wang, Yuhua Jiang, Shikun Wang, Xiaohong Li, Chengxin Liu, Yan Wang, Haijian Wu, Dedong Ma, Shuai Zhang and Lei Fu. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.